Literature DB >> 3193801

Diffusing capacity predicts morbidity and mortality after pulmonary resection.

M K Ferguson1, L Little, L Rizzo, K J Popovich, G F Glonek, A Leff, D Manjoney, A G Little.   

Abstract

Patients who are considered for major pulmonary resection are normally evaluated by spirometry and clinical assessment. Despite this, the morbidity and mortality rates are high after these operations. We retrospectively reviewed results of lung resection performed during a period of 7.5 years in 237 patients to identify other important predictors of morbidity and mortality. There were 144 male and 93 female patients with a mean age of 59.4 +/- 11.4 years. The indication for operation was lung cancer in 199 (76 stage I, 34 stage II, 89 stage IIIA-B), benign disease in 34, and metastatic disease from other primary tumors in four. Lobectomy or bilobectomy was performed in 164 patients and pneumonectomy in 73. Data on 38 preoperative and operative risk factors were correlated with information on 24 postoperative events grouped into four major categories: death, pulmonary complications, cardiovascular complications, and other problems. Logistic regression analysis and chi 2 analysis were used to identify the relationship of the preoperative risk factors to the grouped postoperative complications. The diffusing capacity of the lung for carbon monoxide was the most important predictor of mortality (p less 0.01) and was the sole predictor of postoperative pulmonary complications (p less than 0.005). This diffusing capacity can reveal the existence of emphysematous changes in the lung, even when spirometric values are acceptable, and it usually should be a part of the evaluation of patients being considered for pulmonary resection.

Entities:  

Mesh:

Year:  1988        PMID: 3193801

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  27 in total

1.  BTS guidelines: guidelines on the selection of patients with lung cancer for surgery.

Authors: 
Journal:  Thorax       Date:  2001-02       Impact factor: 9.139

2.  Pulmonary function tests do not predict pulmonary complications after thoracoscopic lobectomy.

Authors:  Mark F Berry; Nestor R Villamizar-Ortiz; Betty C Tong; William R Burfeind; David H Harpole; Thomas A D'Amico; Mark W Onaitis
Journal:  Ann Thorac Surg       Date:  2010-04       Impact factor: 4.330

Review 3.  Risk assessment of lung resection for lung cancer according to pulmonary function: republication of systematic review and proposals by guideline committee of the Japanese association for chest surgery 2014.

Authors:  Noriyoshi Sawabata; Takashi Nagayasu; Yoshihisa Kadota; Taichiro Goto; Hiroyoshi Horio; Takeshi Mori; Shinichi Yamashita; Akinori Iwasaki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-09-27

Review 4.  Preoperative evaluation for lung cancer resection.

Authors:  Dionysios Spyratos; Paul Zarogoulidis; Konstantinos Porpodis; Nikolaos Angelis; Antonios Papaiwannou; Ioannis Kioumis; Georgia Pitsiou; Athanasia Pataka; Kosmas Tsakiridis; Andreas Mpakas; Stamatis Arikas; Nikolaos Katsikogiannis; Ioanna Kougioumtzi; Theodora Tsiouda; Nikolaos Machairiotis; Stavros Siminelakis; Michael Argyriou; Maria Kotsakou; George Kessis; Alexander Kolettas; Thomas Beleveslis; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2014-03       Impact factor: 2.895

Review 5.  Preoperative functional workup for patients with advanced lung cancer.

Authors:  Alessandro Brunelli
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

6.  Racial differences in patients' perceptions of debilitated health states.

Authors:  S Cykert; J D Joines; G Kissling; C J Hansen
Journal:  J Gen Intern Med       Date:  1999-04       Impact factor: 5.128

7.  Effect of thoracotomy and lung resection on exercise capacity in patients with lung cancer.

Authors:  A M Nugent; I C Steele; A M Carragher; K McManus; J A McGuigan; J R Gibbons; M S Riley; D P Nicholls
Journal:  Thorax       Date:  1999-04       Impact factor: 9.139

8.  Robotic surgery can extend surgical indication in patients with lung cancer and impaired function.

Authors:  Giulia Veronesi; Pietro Bruschini; Pierluigi Novellis
Journal:  J Thorac Dis       Date:  2019-11       Impact factor: 2.895

9.  Bronchial sleeve resection or pneumonectomy for non-small cell lung cancer: a propensity-matched analysis of long-term results, survival and quality of life.

Authors:  Saana E M Andersson; Ville H S Rauma; Eero I Sihvo; Jari V Räsänen; Ilkka K Ilonen; Jarmo A Salo
Journal:  J Thorac Dis       Date:  2015-10       Impact factor: 2.895

10.  Impact of Pulmonary Function Measurements on Long-Term Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer.

Authors:  Mark F Berry; Chi-Fu Jeffrey Yang; Matthew G Hartwig; Betty C Tong; David H Harpole; Thomas A D'Amico; Mark W Onaitis
Journal:  Ann Thorac Surg       Date:  2015-05-16       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.